Investment
Features
FeesSafety
Academy
More
Pluang+

Gamma token proposal could enable transferable credits for Bittensor subnets to buy network services.

Protocol Fundamentals
28 Sep 2026
Tokenpost
View Source
Neutral
Gamma token proposal could enable transferable credits for Bittensor subnets to buy network services.

A conceptual Gamma token proposal was introduced at the Exploit Summit on Sept. 28, 2026, aiming to create a transferable credit system for Bittensor subnets. This system would convert part of Alpha token emissions into Gamma credits, which subnets could use to pay for compute, inference, and other network services within the Bittensor ecosystem. The proposal suggests directing some token emissions toward network services instead of immediate market sales, potentially enhancing the utility and value flow within the network. However, the details regarding supply, issuance, redemption, and the relationship between Alpha and Gamma tokens remain undefined, and no formal protocol upgrade or launch timeline has been announced yet.

The Bittensor Gamma token concept is the subject, with Pluang's market data providing context. As of Sep 29, 2026 02:51 WIB, out of 50 major cryptocurrencies priced on Pluang, only 10 rose while 39 fell. EOS gained 8.13% to Rp12.649 with a typical hold time of 87 days, contrasting with DOT which dropped 7.93% to Rp20.879 and had a longer hold time of 120 days and a 60% sell order activity. AXS also declined 7.22% to Rp19.786 with a hold time of 62 days and a near-even sell/buy order split.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App